On Tuesday, Shares of Navidea Biopharmaceuticals Inc (NYSEMKT:NAVB), added 0.51% and closed at $0.870 in the last trading session. NAVI stock opened its last trade at $0.87 and after floating in a range of $0.87 to $0.90. The company’s Market capitalization is $134.82 million with the total Outstanding Shares of 155.72 million. During the 52-week trading session the minimum price at which share price traded, registered at $0.26 and reached to max level of $2.18.The Earnings per Share of the company stands at $-0.14. Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. The company offers Lymphoseek, a receptor-targeted small-molecule radiopharmaceutical used in the evaluation of lymphatic basins that may have cancer involvement in patients; and Manocept platform to target the CD206 mannose receptor expressed on activated macrophages. Its neurological development programs include NAV4694, an Fluorine-18 labeled positron emission tomography imaging agent, which is used as an aid the imaging and evaluation of patients with signs or symptoms of Alzheimers disease and mild cognitive impairment; and NAV5001, an Iodine-123 labeled single photon emission computed tomography imaging agent that is used as an aid in the diagnosis of Parkinsons disease and other movement disorders with potential use as a diagnostic aid in dementia. Navidea Biopharmaceuticals, Inc. has research and development agreements with University of California. The company was formerly known as Neoprobe Corporation and changed its name to Navidea Biopharmaceuticals, Inc. in January 2012.
Shares of Synchrony Financial (NYSE:SYF), added 0.83% and closed at $26.64 in the last trading session. SYF stock opened its last trade at $26.74 and after floating in a range of $26.55 to $26.81. The company’s Market capitalization is $21.98 Billion with the total Outstanding Shares of 833.93 million. During the 52-week trading session the minimum price at which share price traded, registered at $23.25 and reached to max level of $34.60.The Earnings per Share of the company stands at $2.62. Synchrony Financial (NYSE: SYF), a premier consumer financial services company with more than 80 years of heritage, recently declared a multi-year renewal of its program to provide consumer financing for The TJX Companies, Inc., the leading off-price retailer of apparel and home fashions in the United States and worldwide.
Synchrony Financial has offered consumer financing for TJX’s Rewards Credit Card program in the U.S. since 2011. Qualifying cardholders can continue to access loyalty rewards, mobile account administration and other exclusive benefits* with a TJX Rewards® or TJX Rewards Platinum MasterCard® credit card for use in T.J. Maxx, Marshalls, HomeGoods and Sierra Trading Post stores, in addition to the company’s e-commerce sites in the United States.
Cardholders are able to earn $10 in rewards certificates when they spend $200 at any of TJX’s four U.S. retail chains. In Addition To, holders of the TJX Rewards Platinum MasterCard are
able to earn points on purchases made outside of TJX’s retail chains, anywhere MasterCard is accepted.